Advanced Pancreatic Adenocarcinoma

13 clinical trials · Condition

Record	Firm	Date
Combining Epigenetic And Immune Therapy to Beat Cancer. (NCT04705818)	Institut Bergonié	2021-07-23
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors (NCT04616534)	National Cancer Institute (NCI)	2021-06-01
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer (NCT04789486)	Dana-Farber Cancer Institute	2021-05-27
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (NCT04634539)	Jun Gong, MD	2021-05-13
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study (NCT04837118)	M.D. Anderson Cancer Center	2021-02-15
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer (NCT04524702)	Emory University	2020-09-14
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors (NCT01576666)	Novartis Pharmaceuticals	2012-07-01
A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144) (NCT01050283)	Merck Sharp & Dohme LLC	2010-07-01

Every clearance here is in the API, with alerts when new ones post.